UCLA clinical informatics program achieves accreditation

UCLA’s Clinical Informatics Fellowship Program has been approved by the Accreditation Council for Graduate Medical Education (ACGME), making it one of seven programs to earn the approval.

The American Board of Medical Specialties approved clinical informatics as a new, board-eligible subspecialty in 2011. Beginning in 2018, board eligibility in clinical informatics will require completion of a ACGME-accredited fellowship program. There are less than 800 U.S. physicians board-certified in clinical informatics.

Fellows for the two-year fellowship will be chosen in April and are open to graduates of residency programs in any medical specialty.

“Clinical informatics is the scientific discipline focused on how we can deliver knowledge and information precisely where it’s needed in healthcare,” said Douglas Bell, MD, program director of the new fellowship, in a release. “By learning to conduct rigorous research as well as to manage health IT systems, our fellows will close the gap between informatics research and practice by conducting research that’s embedded in and that directly informs clinical informatics practice.”

“Clinical informatics is critical to the success of technology in healthcare, whether it involves electronic health records, imaging informatics or shaping policy on how technology is used,” said Michael Pfeffer, MD, CMIO and acting chief information officer for UCLA Health. “As board-certified physicians in the specialty of their choosing, and as active clinicians using technologies in real time, they will be able to apply their knowledge from the fellowship to develop new and user-friendly ways for technology to help clinicians take better care of patients.”

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.